No Data
No Data
BeiGene to Award Shares Worth $15 Million to 11 Directors
BeiGene (HKG:6160, SHA:688235) will grant restricted share units (RSUs) and performance share units (PSUs) to 11 directors under the firm's 2016 Share Option and Incentive Plan, according to a Tuesday
Hong Kong Stock Concept Tracking | Beijing introduces policies to support the high-quality development of innovative pharmaceuticals, institutions are optimistic about the rise of the domestic innovative drug industry chain (with concept stocks)
Various departments including the Beijing Municipal Medical Security Administration and the Beijing Drug Administration issued a number of measures to support the high-quality development of innovative medicines in Beijing
On the morning of April 16, BeiGene announced on the Hong Kong Stock Exchange that the board of directors has decided to grant restricted share units and performance share units according to the 2016 plan proposal, subject to acceptance and independent sh
On the morning of April 16, BeiGene announced on the Hong Kong Stock Exchange that the board of directors has decided to grant restricted share units and performance share units according to the 2016 plan proposal, subject to acceptance and independent shareholder approval at the annual shareholders' meeting: to the CEO and Chairman of the Board, Ole Qiang, a restricted share unit with a fair value of 6 million US dollars and a fair value of 6 million US dollars on the grant date; and to grant non-executive director Wang Xiaodong a restricted share unit with a fair value of $1,3333 million on the grant date.
Express News | BeiGene: Proposal to grant restricted share units and performance share units to directors
BeiGene (06160.HK): Proposal to grant restricted share units and performance share units to directors
Gelonghui, April 16, 丨 BeiGene (06160.HK) issued an announcement. The board of directors has decided to grant restricted share units and performance share units in accordance with the 2016 plan proposal, subject to acceptance and independent shareholders' approval at the annual shareholders' meeting; granting Mr. Ou a restricted share unit with a fair value of US$6 million on the grant date; granting Mr. Ou a performance share unit with a fair value of US$6 million on the grant date; and awarding restricted share units with a fair value of US$1,333,300 on the grant date; and granting independent non-executive directors (Namely Brandico
Olei Qiang sold 145,600 common shares of BeiGene (06160.HK) off the market, worth approximately US$1,7241 million
On April 15, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on April 15, Ole Qiang sold $145,600 ordinary shares worth $1,7241 million off the market at an average price of $11.8412 per share on April 9. After the sale, Oleqiang's latest shareholding was 74.733,400 shares, and the good position ratio dropped from 5.51% to 5.50%. Additional information: An entity connected to the reporting person sold 11,200
No Data